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Abstract
Background: Uterine leiomyomas (fibroids) are benign smooth muscle tumors that often contain an excessive 
extracellular matrix (ECM). In the present study, we investigated the interactions between human uterine leiomyoma 
(UtLM) cells and uterine leiomyoma-derived fibroblasts (FB), and their importance in cell growth and ECM protein 
production using a coculture system.
Results: We found enhanced cell proliferation, and elevated levels of ECM collagen type I and insulin-like growth 
factor-binding protein-3 after coculturing. There was also increased secretion of vascular endothelial growth factor, 
epidermal growth factor, fibroblast growth factor-2, and platelet derived growth factor A and B in the media of UtLM 
cells cocultured with FB. Protein arrays revealed increased phosphorylated receptor tyrosine kinases (RTKs) of the 
above growth factor ligands, and immunoblots showed elevated levels of the RTK downstream effector, phospho-
mitogen activated protein kinase 44/42 in cocultured UtLM cells. There was also increased secretion of transforming 
growth factor-beta 1 and 3, and immunoprecipitated transforming growth factor-beta receptor I from cocultured UtLM 
cells showed elevated phosphoserine expression. The downstream effectors phospho-small mothers against 
decapentaplegic -2 and -3 protein (SMAD) levels were also increased in cocultured UtLM cells. However, none of the 
above effects were seen in normal myometrial cells cocultured with FB. The soluble factors released by tumor-derived 
fibroblasts and/or UtLM cells, and activation of the growth factor receptors and their pathways stimulated the 
proliferation of UtLM cells and enhanced the production of ECM proteins.
Conclusions: These data support the importance of interactions between fibroid tumor cells and ECM fibroblasts in 
vivo, and the role of growth factors, and ECM proteins in the pathogenesis of uterine fibroids.
Background
Uterine leiomyomas (fibroids; myomas) are the most
common benign tumors of the female reproductive tract
[1] and can cause reproductive problems leading to hys-
terectomy. Although the exact cause of these tumors
remains unknown, steroid hormones and growth factors
and/or their receptors have been reported to play a piv-
otal role in their development [2].
Currently, there are few studies that have investigated
the significance of the "inherent" unique composition of
these tumors in the pathogenesis of uterine leiomyomas.
These firm, circumscribed masses are known to possess a
smooth muscle component, and may often have a signifi-
cant extracellular matrix (ECM). The ECM of fibroids
consists of fibroblasts, often termed myofibroblasts, and
reportedly producing a predominance of collagen types I
and III [3]. The "fibrous/collagenous" component that
exists in these tumors, lends to the use of the colloquial
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reservoir for growth factors, cytokines, chemokines,
angiogenic and inflammatory response mediators, and
proteases produced by tumor cells, that are known to reg-
ulate events such as cell growth and differentiation, and
ECM turnover, which are critical to leiomyoma growth
and regression [4-7]. Furthermore, it has been suggested
that, in general, the growth of tumors is dependent on
interactions between multiple inter-dependent cell types
[8].
Over the years, advances have been made to gain a bet-
ter understanding of cell-cell interactions for various can-
cers and other disease processes using a variety of models
ranging from simple, such as co-culture and inbred/out-
bred rodent models, to the more sophisticated trans-
genic/knockout and xenograft models. It has been
recognized that the interaction between tumors cells and
the stromal compartment may play a significant role in
cancer progression/proliferation. It is speculated that
tumor development is caused by genetic alterations, in
part, and tumor progression results from communication
between neoplastic cells and their microenvironment [9].
Although the cellular, as well as, molecular mechanisms
of tumor progression are unclear, it is believed that the
tumor microenvironment can directly influence tumor
development. The microenvironment includes fibro-
blasts, which represent the most abundant cell type in the
tumor stroma [9] and plays an important role in cancer
development and progression [10]. The microenviron-
ment of neoplastic cells may provide signals that regulate
transcription factors [10]. Fibroblasts may interact with
neoplastic cells and produce ECM [9], and may induce
tumor cells to produce/secrete a variety of soluble factors
or proteins, such as growth factors, into the ECM. Fur-
thermore, fibroblasts and the ECM in tumors may influ-
ence tumor progression [9].
Due to the abundance of ECM often observed in
fibroids, we hypothesized that interactions between leio-
myoma smooth muscle cells and fibroblasts of the ECM
are important in the growth of these tumors and in the
production of growth factors and ECM proteins. In this
study, we used a two-chamber coculture system to mimic
the in vivo condition occurring in uterine leiomyomas of
women, to investigate whether human uterine leiomy-
oma-derived fibroblasts could stimulate cell proliferation
of human uterine leiomyoma cells and the production of
ECM proteins. We also evaluated if this enhanced uterine
leiomyoma cell proliferation could be due to the induc-
tion of growth factors and activation of growth factor
receptors and downstream effectors. Additionally, we
determined if increased production of growth factors
that are important in fibrogenesis and activation of their
receptor signaling pathways could result in enhanced col-
lagen type I synthesis, a major component of the ECM of
leiomyomas in vivo. Through the development of an in
vitro model, we can acquire a better understanding of the
leiomyoma microenvironment, and determine the com-
ponent(s) that play a pivotal role in the pathogenesis of
uterine fibroids, as well as, better define the role of
growth factors and ECM proteins in fibroid development.
Results
Intermediate Filaments and Cell Surface Markers
Human leiomyoma-derived fibroblasts (FB) were nega-
tive for desmin (Figure 1A, center), suggestive of a non-
muscle origin and positive for vimentin (Figure 1A, upper
left). The human uterine leiomyoma (UtLM) cells were
positive for both desmin (Figure 1B, center) and vimentin
(Figure 1B, upper left). Similarly, the human uterine
smooth muscle (myometrial) cells (UtSMC) were positive
for desmin (Figure 1C, center) and vimentin (Figure 1C,
upper left). Normal mouse gamma globulin diluted in
PBS (BioGenex) served as the negative control for both
staining methods (Figures 1A-C, inset: lower right). The
leiomyoma-derived fibroblasts (Figure 1D) were negative
for the oxytocin receptor (OTR), indicating that the FB
were not uterine smooth muscle cells. Both the UtLM
cells (Figure 1E) and UtSMC (Figure 1F) were positive for
the OTR, a G protein coupled receptor expressed in the
myometrium [11] and leiomyomas [12,13]. Normal goat
serum served as the negative control (NC) for the OTR
staining method (Figures 1D-F, inset: upper left)
Increased Cell Proliferation and Proliferating Cell Nuclear 
Antigen (PCNA) Labeling
UtLM cells or UtSMC were cocultured with FB to deter-
mine if coculturing could stimulate proliferation of the
respective uterine smooth muscle cell types (leiomyoma
and myometrial cells). There was a significant (p = 0.004)
increase in the number of UtLM cells when cocultured
with FB compared to UtLM cells cultured alone (Figure
2A). However, there were no significant differences in the
numbers of UtSMC cultured alone and UtSMC cocul-
tured with FB (Figure 2A). There was a significant (p =
0.04) increase in the percent PCNA labeling of UtLM
cells cocultured with FB (19.9%) versus UtLM cells cul-
tured alone (6.45%) (Figure 2B). Also, increased immuno-
expression of PCNA could be seen in UtLM cells
cocultured with FB compared to UtLM cells alone (Figure
2C), No significant differences in percent PCNA labeling
or PNCA immunoexpression were observed between the
UtSMC cocultured with fibroblasts or UtSMC cultured
alone (Figure 2B and 2C). These data support the concept
that the increased PCNA labeling observed in cocultured
UtLM cells in our study is dependent on the presence of
leiomyoma-derived FB. Additional studies were done to
determine the percent PCNA labeling in UtLM cells
cocultured with other UtLM cells. There was no signifi-
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UtLM cells cocultured with UtLM cells (data not shown).
Extracellular Matrix
There was an abundant secretion of collagen type I and
IGF-BP-3 in the media of UtLM cells cocultured or cul-
tured alone, compared to the media of UtSMC under
cocultured or single cultured conditions, or FB cells cul-
tured alone (Figure 3A). Collagen type I was significantly
(p = 0.02) increased in the media of cocultured UtLM
cells compared to UtLM cells cultured alone (Figure 3A
and 3B). There was a significant (p = 0.02) increase in the
secretion of IGF-BP-3 in the media of cocultured UtLM
cells compared to UtLM cells cultured alone. The IGF-
BP-3 levels were also significantly higher in the cocul-
tured UtSMC than UtSMC cultured alone, although min-
imal. There was limited expression of IGF-BP-4
compared to IGF-BP-3 for both UtLM cells and UtSMC
under cocultured or single cultured conditions; although,
there was a significant (p = 0.02) increase in the expres-
sion of IGF-BP-4 in the cocultured UtSMC compared to
UtSMC cultured alone (Figure 3A and 3B). An increase in
IGF-BP-3 and -4 secretion was not detected in the media
of UtLM cells cocultured with UtLM cells when com-
pared to UtLM cultured alone or UtLM cells cocultured
with fibroblasts (data not shown)
Increased Secretion of GFs
Because of the increased proliferation of cocultured
UtLM cells and the induction of ECM proteins, which
was not observed in cocultured UtSMC, we were inter-
ested in mechanisms, primarily cell signaling events that
could possibly explain the differences in growth and ECM
production between the cocultured UtLM cells, and the
UtLM cells cultured alone. We investigated the secretion
of growth factors in the media and found significantly
increased levels of TGF-β1 (p = 0.01), VEGF (p = 0.02)
and EGF (p = 0.004) in the media of cocultured UtLM
Figure 1 Desmin and Vimentin. (A) Uterine leiomyoma-derived fibroblasts (FB) stained negatively for desmin (center) and positively for vimentin 
(upper left). Inset lower right: Negative Control (NC) = Normal Mouse Serum. (B) UtLM cells and UtSMC (C) stained positively for desmin (center) and 
vimentin (upper left). Inset lower right: NC = Normal Mouse Serum. OTR. (D) Leiomyoma-derived FB was negative for the OTR. Inset upper left: NC = 
Normal Goat Serum. Positive staining of the OTR was observed in both UtLM cells (E) and UtSMC (F). Inset upper left: NC = Normal Goat Serum.
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determined by ELISAs (Figure 4A-C). Media levels of
FGF-2, PDGF-A and -B, and TGF-β3 were also found to
be significantly increased (p = 0.02) in cocultured UtLM
cells compared to FB or UtLM cells cultured alone (Fig-
ure 5A and 5B) by western blot analysis; however, levels
of insulin-like growth factor-I (IGF-I) were not detectable
by ELISA or western blot analysis. When UtLM cells were
cocultured with UtLM cells, increased secretions of the
above GFs in media were not detected (data not shown)
Increased Expression of pRTK
Due to increased secretions of GFs observed in the media
of cocultured UtLM cells, we were interested in assessing
the activation of their respective receptors and signaling
pathways. Using a pRTK array kit we found increased
phosphorylation of 16 RTKs in cocultured UtLM cells
compared to UtLM cells cultured alone. These receptor
Figure 2 Assessment of cell proliferation based on cell counts 
and PCNA labeling. (A) Cell proliferation. There was a significant (p 
= 0.004) increase in the number of UtLM cells cocultured with fibro-
blasts (UtLM/FB) compared to UtLM cells cultured alone. There was no 
significant difference observed between UtSMC alone and UtSMC 
cocultured with FB (B) PCNA labeling. The percent PCNA labeling was 
significantly (p = 0.04) higher in UtLM/FB compared to UtLM cells cul-
tured alone; however, there was no significant difference for UtSMC at 
both conditions. (C) PCNA immunoexpression in UtLM cells and 
UtLM/FB. PCNA was expressed in both cocultured and non-cocul-
tured UtLM cells, as well as UtSMC, as indicated by brown nuclear stain-
ing. There was a significant increase in PCNA expression in the UtLM/
FB compared to UtLM cells cultured alone, but not for UtSMC under 
similar conditions. All error bars represent SEM.
Figure 3 ECM Proteins. (A) Western blots. Collagen-I and IGF-BP-3 
protein secretion in media of UtLM cells or UtSCM cultured in the pres-
ence (UtLM/FB or UtSMC/FB) or absence of FB. (B) Densitometry. Col-
lagen I was significantly (p = 0.02) increased in the media of UtLM/FB 
cells compared to UtLM cells cultured alone. There was no difference 
between UtSMC versus UtSMC cocultured with FB. There was a signif-
icant (p = 0.02) increase in the expression of IGF-BP-3 in the cocultured 
UtLM cells compared to UtLM cells or FB cultured alone. Furthermore, 
IGF-BP-3 levels were also significantly higher in the cocultured UtSMC 
than UtSMC and FB cultured alone, but the level was minimal. There 
was a limited expression of IGF-BP-4 compared to IGF-BP-3 for both 
UtLM cells and UtSMC under cocultured or single cultured conditions. 
However, there was a significant (p = 0.02) increase in IGF-BP-4 expres-
sion in the cocultured UtSMC compared to UtSMC cultured alone. All 
error bars represent SEM.
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R), hepatic growth factor-receptor, PDGF-receptor
(PDGF-R), Tie, VEGF-receptor and Eph-R gene families,
which all play important roles in proliferation, fibrogene-
sis, and angiogenesis during tumor development. For this
study, we show the findings for 5 RTKs reported to be
important in the growth/proliferation and/or ECM pro-
duction in uterine leiomyomas. The other elevated RTKs
determined in these assays are involved in primarily
angiogenesis or other biological functions that will be
addressed in future studies. There was increased expres-
sion of phosphorylated receptors v-erb-a erythroblastic
leukemia viral oncogene homolog 4 (or ErbB4), FGF-R2α,
FGF-R3, PDGF-Rα and β and VEGF-R3 in cocultured
UtLM cells compared to UtLM cells cultured alone (Fig-
ure 6A and 6B); however, there was variability among the
intensity values, resulting in a statistically significant (p =
0.02) increase in only the phosphorylated ErbB4, PDGF-
Rα, and PDGF-Rβ (Figure 5B). Interestingly, the
increased expression of these RTKs in the cell lysates was
very similar to what we have observed in leiomyoma tis-
sue [14].
Increased expression of the downstream effector of RTK 
signaling, phosphorylated (p)-MAPK44/42
There was a significant increase in expression of p-
MAPK44/42 in cocultured UtLM cells compared to non-
Figure 4 Secretion of TGF-β1, VEGF and EGF in the media. There 
was a significant increase in the concentration of (A) TGF-β1 (p = 0.01), 
(B) VEGF (p = 0.02) and (C) EGF (p = 0.004) in the media of UtLM/FB 
compared to UtLM cells or fibroblasts (FB) cultured alone by ELISA. All 
error bars represent SEM.
Figure 5 Secretion of FGF-2, PDGF-A and -B, and TGF-β3 in the 
media. (A) Western blots of growth factor proteins. (B) Densito-
metric intensity of growth factor proteins. There was a statistically 
significant (p = 0.02) increase in the secretion of FGF-2, PDGF-A and -B 
and TGF-β3 in the media of UtLM cells cocultured with fibroblasts (Ut-
LM/FB) versus UtLM cells or FB cultured alone. All error bars represent 
SEM.
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7 (p < 0.05) (Figure 7A and 7B), supporting the concept
that increased secretion of GFs and activation of pRTKs
observed in these cells results in enhanced downstream
effector MAPK44/42 activation. The ratio of phosphory-
lated to total (p/t)-MAPK44/42 protein in cocultured and
non-cocultured UtLM cells further indicates the
increased expression level of p-MAPK 44/42 in the cells
under cocultured conditions is due to the elevated phos-
phorylation of the protein not because of increased cell
number (Figure 7B).
Activation of the TGF-β receptor signaling pathway and 
Smad-2 and -3 proteins
Due to the proliferation and excessive protein levels of
collagen type I observed in cocultured UtLM cells, the
TGF-β receptor signaling pathway and down stream
effectors Smad-2 and -3 were investigated. We found that
when TGF-βRI was immunoprecipitated from cocultured
UtLM cells there was increased phosphorylation of serine
sites on these cells compared to UtLM cells or FB cul-
tured alone (Figure 8A). The ratios of p/t for the down-
stream effector proteins, phosphorylated Smad-2 and-3,
were also significantly (p = 0.05) increased in cocultured
UtLM cells compared to non-cocultured cells (Figure 7B).
Total TGF-βRI, as well as, t-Smad-2 and-3, did not differ
significantly between cocultured UtLM versus UtLM
cells cultured alone (Figure 8B).
Discussion
Although the exact etiology of uterine leiomyomas
remains unknown, there is substantial evidence that hor-
mones, such as estrogen and progesterone, partially regu-
late the growth of these tumors [15]. In addition, the
growth-promoting effects observed in uterine leiomyo-
mas may also be mediated by secondary effectors, such as
growth factors, produced by uterine smooth muscle cells
and fibroblasts [7,16]. Uterine leiomyomas often have a
prominent fibrous component comprised of fibroblasts
and various ECM proteins and enzymes that may also be
important in promoting tumor growth [17,18]. Further-
more, evidence exists showing that interactions may
occur between fibroblasts and tumor cells in promoting
tumor growth [19-21].
In recent years, much effort has been made to improve
the understanding of cellular processes involved in cell-
cell interactions in various tumor cells, such as mammary
carcinoma cells, using various models such as coculture,
or conventional or genetically altered animals [20]. To
date, there is an absence of studies that have investigated
cell-cell interactions occurring in the microenvironment
of leiomyomas. In this paper, we conducted experimental
studies using a coculture model to gain a better under-
standing of the interactions between two cell types, leio-
myoma cells and extracellular matrix fibrobasts, which
are the major components of fibroids. We also show the
Figure 7 Detection of phosphorylated (p)-MAPK44/42. (A) West-
ern blots. There was a significant increase in the expression of p-
MAPK44/42 in the UtLM/FB compared to cultures of UtLM cells or FB 
alone at 24 h, 48h and day 7. (B) Densitometry. There was a significant 
increase in the expression of p-MAPK44/42 in cocultured UtLM cells 
compared to non-cocultured UtLM cells and FB at 24 h (p < 0.0001), 48 
h (p = 0.05) and day 7 (p = 0.05). There were no differences observed 
between the culturing conditions for total (t)-MAPK44/42 expression. 
All error bars represent SEM.
Figure 6 Expression of phosphorylated (p)RTKs. (A) pRTK array. 
The array detected activated RTKs for GFs under both culturing condi-
tions (B) Densitometry. There was an overall increase in the expres-
sion of 5 pRTKs in the UtLM/FB compared to UtLM cells cultured alone. 
Significant (p = 0.02) increases in the phosphorylated receptors, ErbB4 
and PDGFα/β, were found in the UtLM/FB compared to UtLM cells cul-
tured alone. All error bars represent SEM.
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tor, cell signaling, proliferation, and extracellular matrix
production. To our knowledge, this is the first study
whereby interactions of human UtLM cells and uterine
leiomyoma-derived fibroblasts have been described.
Our findings show that uterine-leiomyoma-derived FB
can stimulate the proliferation of UtLM cells, and pro-
duction of collagen type I and IGF-BP-3 in the medium of
UtLM cells cocultured with FB. This effect was not seen
when UtLM cells were cultured alone or co-cultured with
other UtLM cells, which indicates the microenvironment
created by coculturing UtLM cells with tumor derived FB
simulates the in vivo condition, and provides an experi-
mental model that can be used to decipher the mecha-
nisms of fibroids growth.
Recently, the tumor microenvironment has been recog-
nized as the place of crosstalk between different cell types
and cellular signaling [10,22]. Tumor cells are known to
secrete a variety of proteins into the ECM microenviron-
ment. In in vitro studies, many have found that growth
factors individually or in combination stimulate uterine
leiomyoma cell proliferation [15,16,23-25]. The prolifera-
tive or fibrogenic growth factors, such as VEGF, FGF-2/
FGF-β, PDGF-A and -B, TGF-β1 and TGF-β3 have been
previously reported to not only stimulate uterine leiomy-
oma cell proliferation in culture, but some have been
reported to enhance collagen production [25]. It is
believed that indeed, the pathogenesis of leiomyomas at
the cellular and molecular levels involves the interactions
of cytokines/growth factors, as well as ECM components,
that all play a pivotal role in the development of these
tumors [26]. Furthermore, it has been suggested that
some of the sulphated glycosaminoglycans (GAGs), such
as heparan sulfate and heparin in the ECM, are involved
in creating a storage depot for biologically active mole-
cules, such as growth factors and enzymes, and under
conditions of hydrolytic degradation of the GAGs there
may be a release of cytokines and other factors that may
promote tumor cell growth and stimulate collagen bio-
synthesis [27]. In this study, we found that many of the
growth factors associated with proliferation and fibro-
genesis, such as EGF, TGF-β1, TGF-β3, VEGF, FGF-2,
and PDGF-A and -B were increased in the media of
cocultured UtLM cells, which suggested that these solu-
ble factors are capable of stimulating the proliferation of
UtLM cells and collagen I production. Our results are
also consistent with other findings in that numerous
growth factors and/or their receptors have been identi-
fied in myometrial and/or uterine leiomyoma tissues, and
Figure 8 Detection of activated TGF-βRI and downstream proteins, p-Smad-2 and -3 at 48 h. (A) Immunoprecipitation of TGF-βRI, blotted 
with anti-phospho-serine. There was increased expression of phospho-serine in immunoprecipitated TGF-βRI in cocultures of UtLM/FB compared 
to cultures of FB or UtLM cells alone. There were no significant differences in total (t)-TGF-βRI expression between the culturing conditions. (b) West-
ern blots of p-Smad-2 and p-Smad-3 and t-Smad-2 and t-Smad-3. Densitometric analyses showed a significant increase in the expression of phos-
pho-Smad-2 (p = 0.001) and phosho-Smad-3 (p = 0.05) in UtLM/FB compared to UtLM cells or FB cultured alone. There was no significant difference 
in t-Smad-2 expression between UtLM/FB and UtLM cells cultured alone. All error bars represent SEM.
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trium [4,16,23,25,28,29].
Microarray analyses have been done to characterize the
gene expression profiles of leiomyoma and matched myo-
metrial smooth muscle cells [30]. The collagen gene has
been identified in leiomyoma smooth muscle cells and
matched myometrial smooth muscle cells [30,31]. It has
been demonstrated that the expression of collagen in
these cells is regulated by TGF-β through the activation
of MAPK [31]. Activation of receptor tyrosine kinases
and TGF-β receptor, and phosphorylation of their down-
stream effectors, MAPK44/42 and Smad2/3, respectively,
in this study indicates that increased levels of growth fac-
tors in cocultured media most likely initiated these sig-
naling cascades. Although there are few reports on
receptor tyrosine kinase signaling in uterine leiomyoma
cells [14,32,33]), one study has shown that treatment of
leiomyoma cells with 17-β estradiol results in enhanced
secretion of PDGF, leading to the activation of the MAPK
pathway and cell proliferation [32]. Expression of PDGF-
A and -B was shown to be higher in leiomyoma tissue
compared to normal myometrial tissue [34]. A study
using reverse-transcriptase polymerase chain reaction
(RT-PCR), recently found that the new PDGF subtype "C"
mRNA was significantly upregulated in leiomyomas by
2.4-fold compared to adjacent normal myometrium,
which was possibly due to involvement of abnormal colla-
gen formation and angiogenesis that may have stimulated
uterine leiomyoma growth [35]. Activation of the PDGF-
R has been associated with stimulation of tumor angio-
genesis in ovarian cancer and neuroblastomas (possibly
by upregulation of VEGF) and recruitment and regula-
tion of tumor fibroblasts [8]. Data from previous studies
in our laboratory have shown increased levels of phos-
phorylated MAPK in uterine leiomyoma compared to
matched myometrial tissue and in UtLM cells following
treatment with IGF-I, and that IGF-I receptor signaling in
leiomyoma tissue is through MAPKp44/42 [14].
Increased mRNA expression levels of collagen types I
and III in the leiomyomas versus normal myometrium
has been previously reported, and it was postulated that
this may be due to ovarian steroids influencing the rate of
ECM protein synthesis or the changing levels of locally
produced growth factors or their receptors [3]. Our study
showed that cocultured UtLM cells produced signifi-
cantly increased levels of collagen-type I, compared to
UtLM cells cultured with UtLM cells, or UtLM cells and
FB cultured alone. The production of collagen type I has
also been shown to be increased in cocultures of fibro-
blasts and MCF7 cells [36]. Furthermore, it has been
shown that leiomyoma cells and normal myometrial cells
treated with PDGF show upregulated expression of colla-
gen I, as well as PCNA [34]. The increased expression of
phosphorylated TGF-β receptor I and Smad2/3 in cocul-
tured UtLM cells compared to UtLM cells cultured alone,
or UtLM cells cultured with UtLM cells would suggest
that activation of TGF-β/Smad pathway, in addition to
increased RTK signaling, resulted in enhanced cell prolif-
eration and increased collagen type I EMC protein and
IGF-BP-3 production in cocultured UtLM cells. Others
have shown an association between TGF-β and IGF-BP-3
in that airway smooth muscle cells treated with 1 ng/ml
TGF-β1 had a 10-fold increase in IGF-BP-3 compared to
controls [37]. Our results are also in agreement with
other studies, in which the authors have found that TGF-
β1 and -β3 are capable of stimulating uterine leiomyoma
cell growth and production of ECM proteins [18,23,24].
Smad 3 and TGF-βR proteins have been shown to be
expressed in both uterine leiomyoma and myometrium
[6,38]. A study has shown that treatment with gonadotro-
pin releasing hormone analogue alters expression of both
proteins, suggesting that the TGF-β system may be
important in the regulation of leiomyoma growth [6].
Microarray experiments have shown that TGF-β1 and -
β3 are increased in fibroids versus myometrium, and this
has been confirmed using RT-PCR [17]. TGF-β, a pleio-
tropic gene, is also known to play a role in fibrosis. The
dysregulation of this gene in the tumors suggests that
TGF-β1 and -β3 may play a key role in ECM formation/
accumulation in fibroids [17].
We and others have reported that IGF-I and/or its
receptor (IGF-IR) are upregulated/activated in both
fibroid tumors [14,16,39] and in uterine leiomyoma cells
[33,40]. Because of lack of detection of IGF-I, or activa-
tion of its receptor, in the present study, we were inter-
ested in identifying factors that may have regulated the
expression and or bioavailability of this growth factor. We
found that the cocultured UtLM cells produced signifi-
cantly higher levels of IGF-BP-3 and IGF-BP-4, while this
binding protein was expressed marginally by UtLM cells
and FB cultured alone. Furthermore, IGF-BP-3 and -4
were minimally expressed by cocultured and non-cocul-
tured normal myometrial cells, or fibroblasts cultured
alone. This would suggest that UtLM are the major pro-
ducers of IGF-BPs, with IGF-BP-3 being secreted more
abundantly than IGF-BP-4. Our results are in agreement
with another in vitro study in which IGF-BP-3 was found
to be the most predominant binding protein in condi-
tioned media cultures from myometrial and uterine
smooth muscle cells [41]. We concluded that lack of IGF-
I detection and IGF-IR activation may have been due to
the high levels of IGF-BP-3 in the media, making signifi-
cant levels of IGF-I ligand biologically unavailable for
IGF-IR binding, or for detection by the methods used in
these studies.
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We conclude that an in vitro coculturing system is a use-
ful model to gain a better understanding of cell-cell inter-
actions that may occur in vivo. We found that fibroblasts
derived from uterine fibroids can stimulate uterine leio-
myoma cell proliferation in culture. This growth may be
mediated, in part, by autocrine and/or paracrine mecha-
nisms that promote the synthesis of soluble factors such
as GFs that are important in stimulating tumor cell prolif-
eration and production of ECM components. Under-
standing the molecular mechanisms of proliferation is
important in identifying cell types, signaling pathways or
tumor components/compartments, such as the ECM,




Uterine Leiomyoma-Derived Fibroblasts (FB)
Primary cultured fibroblasts were taken from leiomyoma
tissue samples obtained from women undergoing hyster-
ectomy at Duke University Medical Center, in accordance
with guidelines by the NIH Office of Human Subjects
Research. The primary culture was established using a
previously described enzymatic digestion method [42].
Briefly, the tissue was minced into about 1-mm cubes and
placed into Dulbecco Modified Eagle's Medium/Nutrient
Mixture F-12 Ham (DMEM/F12) supplemented with 10%
fetal bovine serum, 1% penicillin/streptomycin and 2000
U/ml crude collagenase (Type 1A; Sigma, St. Louis, MO).
Tissue digestion was for 24 h in an incubator at 37°C;
however, 30 min prior to the end of incubation, 2.5%
trypsin was added to the flasks. Dispersed cells were then
centrifuged at 50-100 × g for 3 min. The resulting cell pel-
let was resuspended in medium and remained in culture
for 7 days before subculturing. A FACSVantage SE flow
cytometer equipped with digital electronics (Becton
Dickinson) was used to sort the FB cells from smooth
muscle cells with the OTR antibody (Santa Cruz Biotech-
nology, Inc., Santa Cruz, CA) labeling. Propdium iodide
(PI) was also added to the OTR stained cells prior to
examination to measure membrane integrity. The sorted
cells were analyzed using BD FACSDiVa software with FB
identified as OTR/PI negative. The primary cultured FB
were further conformed by immunocytochemistry and
immunofluorescence staining. FB were immunostained
for the intermediate filament vimentin with primary anti-
body (BioGenex, San Ramon, CA) and a Super Sensitive
link label immunohistochemistry (IHC) detection system
(BioGenex) according to the manufacturer's protocol.
UtSMC and UtLM cells were also stained for vimentin as
positive controls. Desmin, a specific marker for muscle
cells and normal mouse gamma globulin (BioGenex)
served as the negative control. Furthermore, confocal
(Zeiss LSM 510 meta, Carl Zeiss Inc, Oberkochen, Ger-
many) immunofluorescence was done using a primary
anti-goat OTR antibody (C-20; Santa Cruz Biotechnol-
ogy) and donkey anti-goat Alexa Fluor 488 (Molecular
Probes, Eugene, OR) as the secondary antibody to con-
form FB of not uterine smooth muscle origin according to
manufacture's protocol. UtSMC and UtLM staining
served as positive control, and normal goat serum served
as negative control.
Human uterine leiomyoma (UtLM) cells
UtLM cells (GM10964) were purchased from Coriell
Institute for Medical Research (Camden, NJ) and main-
tained in MEM (Gibco Life Technologies, Grand Island,
NY) with supplements at 37°C, with 95% humidity, and
5% carbon dioxide as previously described [33].
Human uterine smooth muscle cells (UtSMC)
UtSMC were also purchased from Clonetics (San Diego,
CA) and grown in media containing supplements and
fetal bovine serum from a SmGM-2 Bullet Kit (Cambrex,
Walkersville, MD) under same condition as UtLM cells.
Cell Coculture
UtLM, UtSMC and FB cells were grown separately under
their specific media conditions as described above. All
cells were seeded at 5 × 10 4 cells/well onto the base of the
well or onto the membrane of an overlying insert (with a
1 mm pore size) of 6-well tissue culture companion plates
(BD Biosciences, Lincoln Park, NJ). The cells grew sepa-
rately for approximately 2 days, and were then cocultured
in the routine medium. After 24 h, the media were
switched to DMEM phenol red free media with stripped
serum (Hyclone, Logan, UT) for the cell proliferation
assays, and DMEM phenol free and serum free for the
western blot, phosphorylated receptor tyrosine kinase
(pRTK) array and ELISA procedures. For the three-cell
culture conditions (UtLM cells or UtSMC cultured with
FB, UtLM cells or UtSMC alone, or FB alone) there were
duplicate wells per condition and three independent
experiments were conducted. Each well contained a total
of 5 ml of medium. Since UtLM cells grow at a rate of
approximately 1 population doubling every 10 days [43],
the cells were allowed to incubate in coculture for 7 days.
On day 7, the cells at the base of the wells were counted
three times using the Coulter Counter Model Z1 (Beck-
man Coulter, Miami, FL) or Cellometer Auto T4 Plus
Counting System (Nexecolm Bioscience LLC, Lawrence,
MA). Aliquots of media samples and cell lysates from the
wells were collected on day 7 in order to allow the
secreted soluble proteins to accumulate to detectable lev-
els. At 24 h, 48 h, and day 7, cell lysates were also har-
vested for RTK arrays or westerns of the receptors and
their target proteins in order to capture their phosphory-
lation status after coculture. All the samples were placed
in a protease inhibitor cocktail (Sigma), and frozen at -
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assays.
Cell Proliferation
For cell proliferation assays, UtLM cells, UtSMC and FB
were plated at density of 2.5 × 10 4 cells/well and allowed
to attach and grow for 4 days on coverslips (Oncor, Gaith-
ersburg, MD) placed at the bottom of each well. There
were three cell culture conditions (UtLM cells or UtSMC
cultured with FB, UtLM cells or UtSMC alone, or FB
alone), which had duplicate wells per condition. On day 3,
media were aspirated from wells, and the wells were filled
with 70% ethanol for 10 min prior to a wash in 1 × auto-
mation buffer for 5 min. The cells were later fixed by plac-
ing 4% paraformaldehyde (Electron Microscopy Sciences,
Hatfield, PA) in wells for 10 min, followed by a rinse with
1 × AB prior to and after incubation in 0.2% triton X-100
(Sigma) for 20 min. The coverslips containing fixed cells
were then removed from the wells, and placed in a
humidity chamber for staining. Incubation in a peroxi-
dase block (BioGenex) was done for 10 min. The cover-
slips were washed before a 30 min incubation in a 1:75
dilution of the primary anti-mouse proliferating cell
nuclear antigen (PCNA) antibody (Chemicon Interna-
tional, Temecula, CA) and staining was done as previ-
ously described [44]. Three independent
immunocytochemical staining experiments were con-
ducted. Percent PCNA labeling was determined by the
number of cells having positively stained (brown) nuclei
divided by 1,000 cells total (i.e., labeled and unlabeled)
and multiplied by 100.
ELISA
ELISA kits were used for determination of TGF-β1 (Ano-
gen, Mississauga, Ontario, Canada), VEGF (IBL, Taka-
saki-shi, Gunma, Japan) and epidermal growth factor
(EGF) (Antigenix America Inc., Huntington Station, NY)
levels. The procedures were performed according to the
manufacturers' protocols. Protein levels in the culture
medium were concentrated 10 × and were measured as
ng/ml or pg/ml. Four replicates of data for each growth
factor were used for statistical analyses.
Western Blot Analysis
To detect GFs in conditioned medium and their signaling
proteins in cell lysates, various primary antibodies (see
below) were used. The cell lysates and concentrated
media (1:10 × concentration, Millipore, Billerica, MA)
were used for western blotting analyses as previously
described [33]. Briefly, blots were incubated overnight
with a specific diluted primary antibody: 1:200 for anti-
collagen-I (Calbiochem, San Diego, CA); 1:300 for anti-
FGF-2 (Santa Cruz Biotechnology) and anti-IGF-BP-3
and -4 (Santa Cruz Biotechnology); 1:500 anti-PDGF-A
and -B (R & D Systems, Minneapolis, MN); 1:1000 for
anti-p-MAPK44/42, anti-t-MAPK44/42 (Cell Signaling
Technology, Inc., Beverly, MA), anti- t-Smad-2 and p-
Smad-2 (Cell Signaling Technology, Inc.), and anti- t-
Smad-3 and p-Smad-3 (Cell Signaling Technology, Inc.);
and 1:3000 for anti-TGF-β3 (Genex Bioscience Inc., Hay-
ward, CA), followed by incubation with the horseradish
peroxidase-conjugated secondary antibody: 1:5000 anti-
mouse (Amersham Biosciences, Piscataway, NJ) for colla-
gen-I; 1:5000 anti-rabbit (Amersham Biosciences) for
FGF-2, TGF-β3, Smad-2, and MAPK44/42; or 1:7000
donkey anti-goat (Santa Cruz Biotechnology) for IGF-BP-
3 and PDGF-A and -B. A densitometer (Fluor ChemTM
8900, Alpha Innotech, San Leandro, CA) was used for
quantitation of band densities. Three independent exper-
iments were conducted and three sets of data were used
for statistical analysis of western blot data.
Human phospho-Receptor Tyrosine Kinase (pRTK) Array
Expression of phosphorylated receptor tyrosine kinases
(pRTKs) was detected at 48 h using a pRTK Array Kit
(R&D Systems). Two hundred micrograms of total pro-
tein from lysates of cocultured UtLM cells or UtLM cul-
tured alone were incubated with a pRTK array membrane
containing anti-pRTK antibodies. The procedures were
performed according to the manufacturer's protocol.
Four replicates of data for each pRTK were used for sta-
tistical analyses.
Immunoprecipitation
For the evaluation of the TGF-β/Smad pathway, immuno-
precipitation was used to pull down the transforming
growth factor-beta receptor I (TGF-βRI) from cell lysates
(50 mg) of UtLM cells cocultured with FB, or UtLM and
FB alone at 48 h using anti-TGF-βRI (1:300 dilution)
(Santa Cruz Biotechnology). The precipitate was then
blotted with a 1:250 dilution of anti-rabbit phosphoserine
(Zymed Laboratories, Inc., San Francisco, CA). A Seize
Primary Immunoprecipitation Kit (Pierce Biotechnology,
Rockford, IL) was used as previously described [14].
Statistical Analysis
Most data were not normally distributed so nonparamet-
ric statistical methods were used to compare UtLM cells
or UtSMC cocultured with FB versus UtLM cells or
UtSMC and/or FB in single culture. These methods
included Mann-Whitney tests and median tests [45].
Mann-Whitney tests were used to determine statistically
significant differences between cocultured and single cul-
tured cells with respect to PCNA labeling, TGF-β3 and
VEGF ELISA data. Median tests were used to compare
single culture versus coculture cells with respect to EGF
ELISA, growth factor and matrix protein intensity data.
For the p- and t- MAPK 44/42 intensity data at 24 h and
48 h, which were more normally distributed, analysis of
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UtLM cells, FB, and cocultured UtLM cell groups. To
identify which groups differed, Fisher's Least Significant
Differences procedure was used. For p-MAPK at day 7
and the RTK array data, the Mann-Whitney test was used
to compare UtLM cells and/or FB and UtLM cells cocul-
tured with FB.
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